Single-Use Technology for Biopharmaceuticals Market: How Disposable Bioprocessing Is Reshaping Biomanufacturing

Single-use technology for biopharmaceuticals refers to disposable bioprocessing equipment, including bioreactors, bags, filters, tubing and connectors, that is used for one batch or a limited number of runs. Polaris Market Research values the single-use technology for biopharmaceuticals market at USD 18.61 billion in 2025 and projects USD 652.44 billion by 2034, a 42.11% CAGR from 2026 to 2034. This article explains what is driving that expansion and where business opportunities are emerging.

Understanding the Single-Use Technology for Biopharmaceuticals Market Landscape

The market sits within the broader bioprocessing equipment industry and supports antibody, vaccine, recombinant protein, therapeutic peptide and advanced therapy production. Compared with stainless steel bioprocessing, single-use systems are preassembled and discarded after each run, so cleaning and cleaning validation are minimal. Polaris Market Research’s comparison reports upfront capital 50–66% below reusable systems but a higher recurring cost per batch. Single-use systems fit multi-product, clinical-scale and contract manufacturing operations, while stainless steel suits large-scale, steady-state, single-product plants.

Key Factors Driving Market Development

Rising biologics and biosimilar manufacturing demand and regulatory standardization are both rated high impact in the report’s driver analysis. The expansion of CDMOs is rated a high-impact opportunity over the medium term, because outsourcing providers handle programs of different stages, product types and volumes and need equipment that can be reconfigured. Supplier consolidation in filtration and purification is rated medium impact. On the other side, USP <665> and <1665> raise the importance of supplier qualification, lengthening evaluation timelines for smaller suppliers and contract manufacturers that lack in-house analytical capability. Cost is another consideration: polyethylene and polypropylene resin prices are up 30%+ since February 2026, linked to U.S. import tariffs and Middle East energy disruption.

Technology and Industry Trends

Material and sensor innovation are advancing together. Gamma-stable polymers address degradation risk during sterilization, while single-use sensors measuring pH, dissolved oxygen and pressure give real-time process information without interrupting a closed system. Product launches reflect the same direction. In July 2026, CPC Biotech introduced RevolveSD, a one-inch single-use product that allows sterile disconnection of bioprocess tubing in fewer steps. In June 2026, Single Use Support launched RoSS.BLST, a blast freezing and thawing platform with recipe-driven control down to -80°C.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:

https://www.polarismarketresearch.com/industry-analysis/single-use-technology-for-biopharmaceuticals-market

Segment and Application Analysis

By product type, bioreactors held the largest share at 38.42% in 2025, while disposable filtration technologies are projected to grow at a 43.17% CAGR as downstream capabilities expand. By application, monoclonal antibody manufacturing held a 40.84% share, and cell and gene therapies are anticipated to register the highest application CAGR at 49.86%, because their smaller, flexible production models suit configurable equipment. Among end users, biopharmaceutical manufacturers held 54.12% of the market in 2025, whereas CDMOs & CROs are expected to grow at a 46.92% CAGR as development and manufacturing activity is outsourced.

Regional Insights and Business Opportunities

North America led with 34.62% of the market in 2025, and Europe followed at 28.16%, where EMA guidance on leachables serves as a benchmark for assessing materials. Asia Pacific is projected to grow at a 47.83% CAGR, and public-private programs show how infrastructure can create demand. In November 2025, the Government of Telangana launched the “1 Bio” facility at Genome Valley, Hyderabad: a 150,000 square foot site with bioreactors of up to 500 liters, supported by roughly USD 15.7 million in state investment and USD 9.4 million from technology partner Thermo Fisher Scientific. Such facilities let startups and smaller contract manufacturers access scale-up capability before committing to dedicated plants.

Competitive Environment

Sartorius, Danaher through Cytiva/Pall and Thermo Fisher Scientific are positioned as market leaders, with integrated portfolios spanning bioreactors, filtration and bags. Merck KGaA is described as a strong challenger on material-science and filtration expertise, while Avantor and Repligen compete through engineered assemblies and downstream and analytics depth. Specialists such as Eppendorf, Corning, Enpro and W. L. Gore & Associates cover niches, and PBS Biotech is an emerging player in vertical-wheel bioreactors. Thermo Fisher completed its Solventum Purification & Filtration acquisition in September 2025 for about USD 4.0 billion in cash. Large suppliers can use M&A to close portfolio gaps, and buyers increasingly weigh validation support and supplier qualification documentation alongside product performance.

Future Outlook

For B2B decision-makers, the single-use technology for biopharmaceuticals market presents opportunities tied to flexibility and compliance. Where stainless steel bioprocessing remains viable for large, steady-state plants, hybrid facilities are common, and single-use adoption is strongest where multi-product agility matters. Single-use sensors and gamma-stable materials will keep improving process control, cell and gene therapies will test small-batch configurability, CDMOs will seek scalable assemblies, and supplier qualification will determine which suppliers earn long-term positions. On Polaris Market Research’s outlook, the market is set to reach USD 652.44 billion by 2034.

More Trending Latest Reports By Polaris Market Research:

Shore Power Market

Commodity Plastics Market

Choline Chloride Market

Air Compressor Market

Commodity Plastics Market

Website Builder Tools Market

Central Nervous System Therapeutics Market

Automotive E-Compressor Market

Benign Prostatic Hyperplasia Surgical Treatment Market